Phase-I Trial of Dose-Intense Liposome-Encapsulated Doxorubicin in Patients with Advanced Sarcoma

To define the maximum-tolerated dose (MTD) of liposome-encapsulated doxorubicin (LED) when used every 2 weeks with granulocyte colony-stimulating factor (G-CSF) in patients with advanced soft tissue sarcoma. Patients and Methods: Doxorubicin encapsulated in egg phosphatidylcholine/cholesterol liposo...

Full description

Saved in:
Bibliographic Details
Main Authors: Casper, E. S., Schwartz, G. K., Sugarman, A., Leung, Denis H. Y., Brennan, M. F.
Format: text
Language:English
Published: Institutional Knowledge at Singapore Management University 1997
Subjects:
Online Access:https://ink.library.smu.edu.sg/soe_research/342
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Singapore Management University
Language: English